|
Published: November 18, 2024
In a small international trial, novel oral medication muvalaplin lowered Lp(a)
American Heart Association Scientific Sessions 2024, Abstract 4171286
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.